IL6 and COVID-19: We observed that elevated IL-6 levels were consistently reported in several COVID-19 studies (Huang et al., 2020; Lai et al., 2020; Xu et al., 2020; Hu et al., 2021b), suggesting that it might be used as a disease severity predictor (Luo et al., 2020).